This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNeill, H. V.
Right arrow Articles by Khan, C. M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNeill, H. V.
Right arrow Articles by Khan, C. M. A.
Agricola
Right arrow Articles by McNeill, H. V.
Right arrow Articles by Khan, C. M. A.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, March 2000, p. 1216-1219, Vol. 66, No. 3
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Development of a Nonantibiotic Dominant Marker for Positively Selecting Expression Plasmids in Multivalent Salmonella Vaccines

Hesta V. McNeill, Katharine A. Sinha,dagger Carlos E. Hormaeche, Jeong Jin Lee, and C. M. Anjam Khan*

Department of Microbiology & Immunology, The Medical School, University of Newcastle, Newcastle NE2 4HH, United Kingdom

Received 20 April 1999/Accepted 10 December 1999

We report the novel application of a herbicide-resistance-based dominant marker for the positive selection of expression plasmids in Salmonella serovar vaccines. The beta -lactamase gene of the plasmid pTETnir15, which expresses fragment C of tetanus toxin (TetC), has been replaced with the bar gene marker. The new plasmid pBAT1 can be positively selected in vitro within Salmonella serovars in the presence of the herbicide DL-phosphinothricin. The expression of TetC remains unaltered, and the Salmonella enterica serovar Typhimurium vaccine strain is stable and immunogenic in vivo.


* Corresponding author. Mailing address: Department of Microbiology, The Medical School, University of Newcastle, Newcastle upon Tyne NE2 4HH, United Kingdom. Phone: 44-191-222-7066. Fax: 44-191-222-7736. E-mail: anjam.khan{at}newcastle.ac.uk.

dagger Present address: Department of Biochemistry, Imperial College, London SW7 2AZ, United Kingdom.


Applied and Environmental Microbiology, March 2000, p. 1216-1219, Vol. 66, No. 3
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Matic, J. N., Terry, T. D., Van Bockel, D., Maddocks, T., Tinworth, D., Jennings, M. P., Djordjevic, S. P., Walker, M. J. (2009). Development of Non-Antibiotic-Resistant, Chromosomally Based, Constitutive and Inducible Expression Systems for aroA-Attenuated Salmonella enterica Serovar Typhimurium. Infect. Immun. 77: 1817-1826 [Abstract] [Full Text]  
  • Fang, C.-M., Wang, J. Y., Chinchilla, M., Levine, M. M., Blackwelder, W. C., Galen, J. E. (2008). Use of mchI Encoding Immunity to the Antimicrobial Peptide Microcin H47 as a Plasmid Selection Marker in Attenuated Bacterial Live Vectors. Infect. Immun. 76: 4422-4430 [Abstract] [Full Text]  
  • Stephens, J. C., Darsley, M. J., Turner, A. K. (2006). Stabilization of a Plasmid Coding for a Heterologous Antigen in Salmonella enterica Serotype Typhi Vaccine Strain CVD908-htrA by Using Site-Specific Recombination. Infect. Immun. 74: 4383-4386 [Abstract] [Full Text]  
  • Garmory, H. S., Leckenby, M. W., Griffin, K. F., Elvin, S. J., Taylor, R. R., Hartley, M. G., Hanak, J. A. J., Williamson, E. D., Cranenburgh, R. M. (2005). Antibiotic-Free Plasmid Stabilization by Operator-Repressor Titration for Vaccine Delivery by Using Live Salmonella enterica Serovar Typhimurium. Infect. Immun. 73: 2005-2011 [Abstract] [Full Text]